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ST-Segment Elevation
Myocardial Infarction,
Cardiac Arrest, and
Cardiogenic Shock
An Interventional Triumvirate of Opportunity*
Karl B. Kern, MD
Tucson, Arizona
Cardiogenic shock following myocardial infarction remains
a significant clinical challenge. Newly reported 30-day
mortality rates remain in the 40% range and are not affected
by the use of intra-aortic balloon counterpulsation (1). Few
cardiac conditions are more deadly. The major exception is
patients who suffer cardiac arrest with their ST-segment
elevation myocardial infarction (STEMI) and, once resus-
citated, manifest cardiogenic shock. Garot et al. (2) from
Paris have shown that such patients have a 6-month
mortality of 67%. In this post–cardiac arrest population,
multiple stepwise logistic regression analysis showed the
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absence of shock on admission to be independently associ-
ated with improved 6-month survival (odds ratio [OR]:
12.66, 95% confidence interval [CI]: 3.39 to 47.63) (2). In
a separate report, Mooney et al. (3) found similar poor
outcomes among those resuscitated from cardiac arrest with
subsequent cardiogenic shock. In their series of 140 patients
resuscitated from out-of-hospital cardiac arrest, 61 (44%)
manifested cardiogenic shock. Post–cardiac arrest patients
with shock had a significantly higher in-hospital mortality
rate than those without (62% vs. 30%; OR: 0.26, 95% CI:
0.13 to 0.53).
Mylotte and these same Parisian investigators (4) report
in this issue of JACC: Cardiovascular Interventions their
remarkable experience in treating this very sick post-
resuscitation population with cardiogenic shock. Between
1998 and 2010, Mylotte et al. conducted a multicenter,
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nd PhysioControl.prospective, data collection of consecutive, unselected pa-
tients presenting with STEMI. Among these 11,530
STEMI patients, 496 (4.3%) were resuscitated from cardiac
arrest. The cohort for their reported observational study
included 272 patients who manifested cardiogenic shock
after being resuscitated. Most of these patients (174) were
found to have multivessel coronary artery disease. Among
the patients with multivessel disease, 2 revascularization
approaches were compared: culprit-only or multivessel pri-
mary percutaneous coronary intervention (PCI). Survival at
6 months was significantly greater in patients undergoing
multivessel PCI than in those treated with culprit vessel
PCI only (43.9% vs. 20.4%; p  0.002).
Though obviously not a prospective, blinded, or random-
ized trial, these results are consistent with the growing
database of cohort studies showing remarkable outcome
improvements with more aggressive post-resuscitation care.
Sunde et al. (5) were the first to report their experience
with more aggressive post-resuscitation care improving
long-term survival after cardiac arrest. They doubled their
historical survival to discharge with favorable neurological
outcome rate from 26% to 56%. The most important
post–cardiac arrest treatments were therapeutic hypother-
mia and early coronary angiography. The literature now
reports the outcomes of over 1,500 cardiac arrest patients so
treated after successful resuscitation (6). This worldwide
experience shows that aggressive post-resuscitation care is
achievable, safe, and beneficial in those suffering cardiac
arrest in the context of STEMI (2,7–10), non-STEMI
(11–13), and now STEMI with associated cardiogenic
shock (4). Not only was 6-month survival better with full
revascularization by multivessel PCI, but remarkably 90% of
those who survived had favorable neurological recovery (4).
Mylotte et al. achieved remarkable outcomes in this, the
very highest risk subgroup of all STEMI patients (4).
Maynard et al. (14) from Seattle showed the high risk
associated with such patients using a mortality model based
on the nearly 16,000 consecutive PCI in Washington state.
The overall mortality rate was 1%, whereas the mortality
rate in post-resuscitated patients was 19%. Interestingly, in
their analysis, compared with post-resuscitation status, only
cardiogenic shock had a higher OR for predicting death
post-PCI. Manifesting cardiogenic shock after resuscitation
from cardiac arrest combines these 2 highest-risk conditions
for death after STEMI.
Mylotte et al. (4) publish the first data substantiating the
concept that a complete revascularization, as opposed to a
culprit-only strategy in those with cardiogenic shock, can
improve outcome. Though such a strategy has been es-
poused previously, this is the first clinical evidence of efficacy
for this approach. Perhaps they were successful in showing
such an improvement because of the very high-risk popu-
lation studied.
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127Calculating the observed-to-expected ratio for death
from their recent experience in treating those with STEMI
complicated by cardiac arrest and then cardiogenic shock is
revealing (4). According to their earlier report, the expected
mortality in such patients is 67%. These investigators from
Paris found that multivessel PCI performed immediately
upon arrival at the hospital improved outcome, lowering the
mortality rate to 56%, thereby achieving an observed-to-
expected ratio of 0.84 (p  0.03). This approach works in
these very sick patients!
Once again these pioneers from Paris are leading the way.
They have reset the bar in treating the “sickest of the sick”
among cardiac patients. Hopefully, such therapy can be
extended to all post–cardiac arrest patients, not just in Paris,
but in other communities as well. This will likely only occur
when we recognize the importance of complete, emergency
revascularization in this very sick subgroup of STEMI
patients.
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